MACQUARIE GROUP LTD - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 148 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$49,000
-99.7%
22,269
-99.4%
0.00%
-100.0%
Q2 2021$15,059,000
+17.2%
4,015,904
+1.9%
0.01%
-33.3%
Q1 2021$12,853,000
+30.4%
3,942,584
+36.4%
0.02%
+28.6%
Q4 2020$9,853,000
-26.4%
2,889,399
-12.0%
0.01%
-39.1%
Q3 2020$13,393,000
+22.6%
3,282,673
+1.6%
0.02%
+21.1%
Q2 2020$10,922,000
+56.3%
3,231,404
+7.7%
0.02%
+35.7%
Q1 2020$6,989,000
-30.2%
2,999,564
+9.1%
0.01%0.0%
Q4 2019$10,006,000
-64.4%
2,748,704
-18.9%
0.01%
-70.2%
Q3 2019$28,105,000
-63.1%
3,388,187
-61.7%
0.05%
+9.3%
Q2 2019$76,209,000
+158.9%
8,851,074
+221.4%
0.04%
-14.0%
Q1 2019$29,440,000
+41.6%
2,754,038
+15.9%
0.05%
+25.0%
Q4 2018$20,795,000
-1.5%
2,376,558
+89.1%
0.04%
+17.6%
Q3 2018$21,115,000
+17.5%
1,256,843
+46.6%
0.03%
+9.7%
Q2 2018$17,965,000
+150.8%
857,108
+92.5%
0.03%
+138.5%
Q1 2018$7,163,000
-13.3%
445,170
+2.1%
0.01%
-13.3%
Q4 2017$8,259,000
-60.3%
435,866
-70.5%
0.02%
-59.5%
Q3 2017$20,817,000
+24.3%
1,479,513
-34.2%
0.04%
+19.4%
Q2 2017$16,744,000
+25.4%
2,247,493
+9.4%
0.03%
+29.2%
Q1 2017$13,348,000
+67.3%
2,053,610
+14.0%
0.02%
+60.0%
Q4 2016$7,977,000
-1.3%
1,800,669
+4.0%
0.02%
-6.2%
Q3 2016$8,086,000
-62.8%
1,731,582
-47.6%
0.02%
-23.8%
Q2 2016$21,714,000
+163.5%
3,305,096
+155.1%
0.02%
+23.5%
Q1 2016$8,241,000
+20.9%
1,295,689
+14.6%
0.02%
+21.4%
Q4 2015$6,816,000
+10.2%
1,130,324
+9.3%
0.01%
+7.7%
Q3 2015$6,186,000
+10.0%
1,034,429
+25.8%
0.01%
+18.2%
Q2 2015$5,623,000
+32.7%
822,113
+17.8%
0.01%
+37.5%
Q1 2015$4,236,000
+26.8%
697,898
+44.7%
0.01%
+14.3%
Q4 2014$3,342,000
+1.0%
482,220
+18.6%
0.01%0.0%
Q3 2014$3,309,000
+28.4%
406,462
+28.2%
0.01%
+16.7%
Q2 2014$2,578,000
+17.7%
317,086
+13.5%
0.01%
+50.0%
Q1 2014$2,191,000
+20.0%
279,451
+35.5%
0.00%
+33.3%
Q4 2013$1,826,000
+16.5%
206,311
+10.4%
0.00%0.0%
Q3 2013$1,568,000
+8.4%
186,911
-3.7%
0.00%0.0%
Q2 2013$1,447,000194,0310.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders